Lurasidone is an atypical antipsychotic that has a unique chemical structure compared to other existing antischizophrenia drugs and is believed to have affinity for dopamine D2, serotonin (5-HTChemicalbook2A) and (5-HT 7) receptors and antagonistic effects in these receptors. Furthermore, lurasidone had a partial agonistic effect on the serotonin (5-HT 1 A) receptor and had no significant affinity for histamine H1 or muscarinic M1 receptors. It has been shown to mediate the efficacy of lurasidone in schizophrenia through a combination of central-type 2 dopamine (D2) and type-25 HT 2 A receptor (5 HT 2 A) receptor antagonism.Lurasidone hydrochloride is an organic synthesis intermediate and pharmaceutical intermediate, which can be used in organic synthesis process and chemical medicine synthesis process in laboratory research and development.